"The skin as a sensor and effector organ orchestrating local and systemic immune responses (SFB CRC TRR 156)"

-          Subproject C03: "Impact of reactive oxygen species and NF-kB signaling during hapten- induced skin inflammation"
-         Funding Agency: DFG
-         Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling
-         Funding period (2. funding period): 01.07.2019-30.06.2023


"Dr. K. H. Eberle Forschungspreis 2020"

-         Funding Agency: Dr. K. H. Eberle Foundation
-         Applicant: Prof. Dr. André Martins, Dr. Sabrina Hoffmann
-         Funding period: 2021 – 2022


"Heating up the immune system Immuno-thermal therapy for targeting immune networks to control melanoma metastasis"

-          Funding Agency: Fritz Bender Stiftung
-          Principal Investigators: Prof. Dr. Bettina Weigelin
-          Funding period: 2022 - 2022


"Health first: Translationale Forschung und Infrastruktur in Tübingen - Immuno-PET"

-          Funding Agency: MWK
-          Principal Investigators: Prof. Dr. Bernd Pichler
-          Funding period: 2021 - 2022


"Health first: Translationale Forschung und Infrastruktur in Tübingen - Radiopharmazie Infrastruktur"

-          Funding Agency: MWK
-          Principal Investigators: Prof. Dr. Bernd Pichler
-          Funding period: 2021 - 2022


"PET Imaging of Alpha-Synuclein Fibril Formatio (PET-AlphaSy)"

-          Funding Agency: EU
-          Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Kristina Herfert, Dr. Andreas Maurer
-          Funding period: 01.09.2018-31.08.2022


"NAPKON - Nationales Pandemie Kohorten Netz - Nationales Forschungsnetzwerk der Universitätsmedizin"

-          Funding Agency: BMBF
-          Principal Investigators: Dr. Christoph Trautwein
-          Funding period: 2021 - 2021


"Targeting therapeutic windows in essential cellular processes for tumor therapy ( SFB FOR 2314)"

-          Subproject Z02: "Multiparametric Imaging and Molecular Probed Design Platform"
-          Subproject TP 01: "Therapeutic Induction and Image Guided Exploration of Cellular senescence for Cancer Therapy"
-          Funding Agency: DFG
-          Subproject Z02 Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Antti Poso
-          Subproject TP 01 Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Lars Zender
-          Funding period (2. funding period): 16.07.2018-15.07.2021


"Platelets – Molecular, cellular and systemic functions in health and disease (SFB TRR 240)"

-         Subproject Z04: "Metabolic Imaging"
-         Funding Agency: DFG
-         Subproject leader: Prof. Dr. Bernd Pichler
-         Funding period: 01.07.2018 – 30.06.2022


"Innovative Training Network towards raising and supporting the next generation of creative and entrepreneurial cross-speciality imaging experts (HYBRID)”

-          Funding Agency: EU
-          Principal Investigator: Prof. Dr. Bernd Pichler
-          Funding period: 01.10.2017-30.09.2021


"Trimodal imaging of human brain networks using simultaneous PET/MR/EEG"

-          Funding Agency: DFG
-          Applicants: Prof. Dr. Christian la Fougère, Prof. Dr. Niels Focke, Prof. Dr. Bernd Pichler
-          Funding period: 01.03.2018-28.02.2021


"Nicht-invasive Visualisierung und Verfolgung spezifischer Zellpopulationen mittels Positronen-Emissions-Tomographie"

-          Funding Agency: Dr. Karl Helmuth Eberle-Stiftung
-          Principal Investigators: Prof. Dr. Robert Feil, Prof. Dr. Bernd Pichler, Dr. Susanne Feil
-          Funding period: 01.12.2017-30.11.2020


"Investigation of a potential new PET tracer for alpha-synuclein pathology in the brain"

-          Funding Agency: Michael J. Fox Foundation
-          Principal Investigator: Dr. Kristina Herfert
-          Funding period: 01.10.2018-31.01.2020


"Radiolabeled benzoxazinoles - a unique ß-amyloid PET-tracer class allowing the dichotomous detection of parenchymal and vascular ß-amyloid deposits"

-          Funding Agency: DFG
-          Applicant: Prof. Dr. Bernd Pichler
-          Funding period: 01.02.2017-31.01.2020


 "The skin as a sensor and effector organ orchestrating local and systemic immune (SFB TRR 156)"

-          Subproject C03: "Impact of reactive oxygen species and NF-kB signaling during hapten- induced skin inflammation"
-          Funding Agency: DFG
-          Subproject leaders: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling
-          Funding period (1. funding period): 01.07.2015-30.06.2019


"Innovative cancer therapy management: First in human senescence imaging (SenPET)"

-          Funding Agency: EU
-          Applicant: Prof. Dr. Bernd Pichler
-          Funding period: 01.04.2018 bis 30.09.2019


"Systems Biology Supports Multiscale Analysis of Imaging, Omics and Clinical Data to Improve Diagnosis and Therapy of HCCs (MultiscaleHCC)"

-          Funding Agency: BMBF
-          Coordinator: Prof. Dr. Bernd Pichler
-          Funding period (2. funding period): 01.05.2017-30.04.2019


"New Molecular-Functional Imaging Technologies and Therapeutic Strategies for Theranostic of Invasive Aspergillosis (MATHIAS)”

-          Funding Agency: EU
-          Coordinator: Prof. Dr. Bernd Pichler
-          Funding period: 01.10.2013-30.09.2018


 “Multimodal Imaging of rare Synucleinopathies (MultiSyn)”

-          Funding Agency: EU
-          WP1 leader: Prof. Dr. Bernd Pichler
-          Funding period: 01.10.2013-30.09.2018


“Targeting therapeutic windows in essential cellular processes for tumor therapy ( SFB FOR 2314)”

-          Subproject Z02: “Multiparametric and metabolic Imaging“
-          Funding Agency: DFG
-          Subproject Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Andreas Beilhack
-          Funding period: 02.07.2015-01.07.2018


“Multiparametric Tumor Imaging and Beyond: Towards Understanding in vivo Signals (IMAGELINK)”

-        Funding Agency: EU
-        Applicant: Prof. Dr. Bernd Pichler
-        Funding period: 01.06.2013-31.05.2018


“Platelets - Molecular Mechanisms and Translational Implications (KFO 274)”

-        Funding Agency: DFG
-        Subproject Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Robert Feil, Prof. Dr. Tilman Schäffer
-        Funding period (2. funding period): 01.01.2015-31.12.2017


“Multimodale Bildgebung bei Patientinnen mit primärem Mammacarcinom”

-        Funding Agency: DFG
-        Applicants: Prof. Dr. Konstantin Nikolaou, Prof. Dr. Bernd Pichler, Prof. Dr. Christian la   Fougère, Prof. Dr. Falko Fend, Prof. Dr. Sara Brucker, Prof. Dr. Markus Hahn
-        Funding period: 06.04.2016-31.10.2017


“Immunotherapy: Molecular Basis and Clinical Application (SFB 685)”

-        Funding Agency: DFG
-        Subproject leaders: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling
-        Funding period (2. funding period): 01.07.2013-30.06.2017


“Systems Biology Supports Multiscale Analysis of Imaging, Omics and Clinical Data to Improve Diagnosis and Therapy of HCCs (MultiscaleHCC)”

-       Funding Agency: BMBF
-       Coordinator: Prof. Dr. Bernd Pichler
-       Funding period (1. funding period): 01.05.2014-30.04.2017


Werner Siemens-Foundation endowed professorship “functional imaging”

-        Funding Agency: Werner Siemens-Foundation, Zug, Switzerland
-        Applicants: Prof. Dr. Claus Claussen, Dr. Bernd Pichler
-        Funding period: 01.01.07-31.12.16


Werner Siemens Imaging Center

-        Funding Agency: Werner Siemens-Foundation, Zug, Switzerland
-        Applicant: Prof. Dr. Bernd Pichler
-        Funding period: 2012 – 2015


“Holistic Multi-Scale Modeling of Targeted Protein Therapeutics Action: Towards Predicting Effective Treatment of Cancer (PREDICT)”

-        Funding Agency: BMBF
-        Subproject 3 leader: Prof. Dr. Bernd Pichler
-        Funding period: 01.01.2013–31.12.2015


“European Training Network for Excellence in Molecular Imaging in Diabetes (BetaTrain)”

-        Funding Agency: EU
-        Leader of subprojects: Prof. Dr. Bernd Pichler
-        Funding period: 01.01.2012-31.12.2015


“Therapy of Urinary Incontinence by Cell-based Regeneration of the Sphincter Muscle of the Urethra (SFB KFO 273)”

-        Funding Agency: DFG
-        Subproject Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Claus Claussen, Prof. Dr. Ulrich Kramer
-        Funding period: 01.12.2012 – 30.11.2015


 “Biomarkers and molecular tumor classification for non-genotoxic carcinogenesis (MARCAR)”

-         Funding Agency: EU
-         WP7 Leader: Prof. Dr. Bernd Pichler
-         Funding period: 01.03.2012-30.05.2015


“Platelets - Molecular Mechanisms and Translational Implications (KFO 274)”

-         Funding Agency: DFG
-         Subproject Leader: Prof. Dr. Bernd Pichler
-         Funding period (1. funding period) : 01.12.2011-30.11.2014


"PhD Research Training Group “Preclinical Molecular Imaging”

-         Funding Agency: Werner Siemens-Foundation, Zug, Switzerland
-         Applicant: Prof. Dr. Bernd Pichler
-         Funding period: 2009-2014


“Neuartige multifunktionale, nanopartikuläre Formulierung für kombinierte Diagnose und Therapie maligner Erkrankungen (NanoGuide)”             

-         Funding Agency: BMBF
-         Subproject Leader: Prof. Dr. Bernd Pichler
-         Funding period: 01.01.2011-31.12.2013


“Immunotherapy: Molecular Basis and Clinical Application (SFB 685)”

-         Funding Agency: DFG
-         Subproject leaders: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling
-         Funding period (1. funding period): 01.07.2009-30.06.2013


“MRI-based attenuation correction of PET images in clinical PET/MR”

-        Funding Agency: DFG
-        Applicant: Prof. Dr. Bernd Pichler
-        Funding period: 02.04.2010-01.04.2013


“Evaluierung von Cholin-Derivaten zur Anwendung in der nicht-invasiven Bildgebung beim Prostata-Karzinom”

-        Funding Agency: DFG
-        Applicants: Prof. Dr. Bernd Pichler, PD Dr. Gerald Reischl
-        Funding period (2. funding period): 01.06.2010-31.12.2012


“Understanding and Overcoming Therapy Resistance of Solid Tumours (SFB 773)”

-        Funding Agency: DFG
-        Subproject leaders: Dr. Bernd Pichler, Prof. Dr. Claus Claussen, Prof. Dr. Hans-Jürgen Machulla
-        Funding period: 01.07.2008-30.06.2012


“PET- und MR-Imaging des Prostatakarzinoms mit Hilfe spezifischer anti-PSMA monoklonaler Antikörper und rekombinanter Antikörperfragmente”

-         Funding Agency: DFG
-         Applicants: Prof. Dr. Ursula Elsäßer-Beile, Prof. Dr. Bernd Pichler
-         Funding period: 01.04.2009-31.03.2012


“Angiogenese-Targeting für Diagnose und Therapie – MoBiMed”

-         Funding Agency: BMBF
-         Subproject Leader: Prof. Dr. Bernd Pichler
-         Funding period: 01.09.2008-29.02.2012


“Development of novel PET detectors based on Geigermode Avalanche Photodiodes (G-APDs) for Molecular Imaging Applications”

-         Funding Agency: DFG
-         Applicant: Prof. Dr. Bernd Pichler
-         Funding period: 01.03.2009-29.02.2012


“A systems biology approach towards predictive cancer therapy”

-         Funding Agency: BMBF
-         Subproject Leader: Prof. Dr. Bernd Pichler
-         Funding period: 01.07.2008-31.12.2011


“Development and Validation of a combined PET/MRI Scanner for Biomedical Research”

-          Funding Agency: DFG
-          Applicant: Prof. Dr. Bernd Pichler
-          Funding period: 01.10.2008-30.09.2011


“Development of Methods, Protocols and Databases to Reduce the Number and to Decrease the Exposure Level of Animals by High Resolution Positron Emission tomography and multimodal imaging”

-          Funding Agency: BMBF
-          Applicant: Prof. Dr. Bernd Pichler
-          Funding period: 01.03.2008-28.02.2011


Subproject: “Aβ and Tau aggregation: Initiation, modulation and imaging”

-          Funding Agency: BMBF
-          Subproject Leaders: Prof. Dr. Matthias Jucker, Dr. Bernd Pichler, Prof. Dr. Philipp Kahle
-          Funding period: 01.10.2007-30.09.2010


“Evaluierung von Cholin- und Acetat-Derivaten zur Anwendung in der nicht- invasiven Bildgebung beim Prostata-Karzinom”

-         Funding Agency: DFG
-         Applicants: Prof. Dr. Hans-Jürgen Machulla, Dr. Gerald Reischl, Dr. Bernd Pichler
-         Funding period: (1. funding period) 01.11.2006-31.10.2009


“Non-invasive Imaging of T Cell Trafficking”

-         Funding Agency: R03 National Institute of Health, USA
-         Applicant: Dr. Bernd Pichler
-         Funding period: 01.09.2005-31.08.2008


 “An integrated PET-MRI-System for Molecular Imaging”

-         Funding Agency: R21 National Institute of Health, USA
-         Applicant: Dr. Bernd Pichler
-         Funding period: 01.09.2004-30.04.2008